1P-LSD in Dominica: not individually verified

What Dominica HAS confirmed for related substances

These are related compounds, not 1P-LSD. Their status may or may not reflect 1P-LSD’s. Confirm 1P-LSD directly with Dominica's national drug authority or your embassy.

• LSA (Morning Glory)a related compound, not 1P-LSD

  LSA is a Class A controlled drug under the Drugs (Prevention of Misuse) Act, Chapter 40:07. Part I of the Third Schedule prints the entry «Lysergamide». This row is the entry the compilation missed. Lysergamide is d-lysergic acid amide, which is ergine, which is LSA, and it is printed in Part I as an entry in its own right between «Levorphanol» and «Lysergide and other». The compilation recorded ergometrine and ergine as the printed entry for this row; neither word is in the Act, and the Act's own name for the substance was on the page. Section 4(1)(a) makes a controlled drug any substance for the time being specified in Parts I, II or III of that Schedule and section 4(1)(b) makes a Class A drug any substance specified in Part I. Paragraph 4 of Part I extends the entry to any salt of the listed substance and paragraph 5 to any preparation or other product containing it. The placement is stated as at the revision this text carries: the Third Schedule occupies printed pages 30 to 33 and those pages are authorised by the footer note «L.R.O. 1/1991». Section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, and this consolidation reproduces no Order made after that authorisation, so the placement stated here is a floor and not a closed account of the position today. The compilation recorded «ERGOMETRINA; ERGINA (LSA)» as the printed entry for this row. That string does not appear anywhere in this Act; the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act.

  Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 4, 5, 6, 7, 27, 29 and 32 and the Third and Fourth Schedules · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The entry relied on for this row is «Lysergamide» in Part I, read on printed page 30 or 31 as a page image rendered from the scan, because the text layer of this scan silently drops the «Part II» and «Part III» headings and one numbered paragraph in each of those Parts · the complete Class A, Class B and Class C lists were read that way and not by searching the text. The Third Schedule pages carry the footer «L.R.O. 1/1991» and the Fourth Schedule figures quoted here were read off the page images of printed pages 34 and 35. This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «lsa national source» rather than an address, and no per row source exists. The compilation recorded «ERGOMETRINA · ERGINA (LSA)» as the printed entry for this row. That string does not appear anywhere in this Act · the Act is written in English and that record's quotation column is largely in another language, which is a property of the record rather than of the instrument, so it is reported here and is not offered as a quotation from the Act. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full from the Government of Dominica laws site at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Read as at 22 September 2026. · Verified September 21, 2026

• LSDa related compound, not 1P-LSD

  LSD is a Class A controlled drug under the Drugs (Prevention of Misuse) Act, Chapter 40:07. Part I of the Third Schedule prints the entry «Lysergide and other». The printed entry is truncated by the typesetting: «Lysergide and other» is the last line of the Part I column on printed page 30 and «N-alkyl derivates» is the last line of the second column on printed page 31, with the whole Class A list between them. The two are quoted here as each page prints them and the joined phrase is not offered as a quotation. Lysergide itself is unambiguous on the page and is what this row rests on; the separate entry «Lysergamide» is printed four lines above it. Section 4(1)(a) makes a controlled drug any substance for the time being specified in Parts I, II or III of that Schedule and section 4(1)(b) makes a Class A drug any substance specified in Part I. Paragraph 4 of Part I extends the entry to any salt of the listed substance and paragraph 5 to any preparation or other product containing it. The placement is stated as at the revision this text carries: the Third Schedule occupies printed pages 30 to 33 and those pages are authorised by the footer note «L.R.O. 1/1991». Section 4(3) lets the Minister amend Parts I to III by Order after consulting the Advisory Council, and this consolidation reproduces no Order made after that authorisation, so the placement stated here is a floor and not a closed account of the position today. The compilation recorded «Lysergide» as the printed entry for this row. That word is English and it is on the page, but it is a fragment: the Act prints «Lysergide and other» and sets the rest of the entry on the following printed page, so the record quoted part of an entry rather than an entry.

  Dominica, the Drugs (Prevention of Misuse) Act, Act 20 of 1988 as amended by Act 15 of 1989 and Act 15 of 1990, revised edition Chapter 40:07, sections 4, 5, 6, 7, 27, 29 and 32 and the Third and Fourth Schedules · read from the 64 page scanned chapter held in this repository at research/instruments/dominica/dm-drugs-prevention-of-misuse-1988.pdf, sha256 30ca6c954678725f8bd4ea81de7b081e5b3ef5ef9015d05e357de1992c62ab30, with its text layer at dm-drugs-prevention-of-misuse-1988.txt, sha256 d47a9b795cabe1a1250ebd6ec3e13e4ccb6367708b69fded78a8eb22b7ab1465. The entry relied on for this row is «Lysergide and other» in Part I, read on printed page 30 or 31 as a page image rendered from the scan, because the text layer of this scan silently drops the «Part II» and «Part III» headings and one numbered paragraph in each of those Parts · the complete Class A, Class B and Class C lists were read that way and not by searching the text. The Third Schedule pages carry the footer «L.R.O. 1/1991» and the Fourth Schedule figures quoted here were read off the page images of printed pages 34 and 35. This citation is document level and not per substance: the compilation's links column for this row holds the constructed text «lsd national source» rather than an address, and no per row source exists. The compilation recorded «Lysergide» as the printed entry for this row. That word is English and it is on the page, but it is a fragment: the Act prints «Lysergide and other» and sets the rest of the entry on the following printed page, so the record quoted part of an entry rather than an entry. The Part and Class placement stated for this row is not printed in the quotation column of the compilation read alongside the Act: measured across that compilation, not one of its 88 rows carries a Part, a Class or a Schedule marker of any kind, and its instrument column says only that there is a controlled-drug schedule without naming which of the four Schedules that is. Every division named in this cell is therefore taken from the printed Third Schedule pages of the Act itself. Second instrument relied on: Dominica, the Drugs (Prevention of Misuse) (Amendment) Act 2020, Act No. 16 of 2020, assented to and gazetted 30 October 2020 and passed in the House of Assembly on 26 October 2020, a four page Act read in full from the Government of Dominica laws site at https://dominica.gov.dm/laws/2020/Drug%20Prevention%20(Amendment)%20Act%202020.pdf, sha256 c5f6a5b47cee1ffce3f88993d72163a1f0ba6a1f3cf68c31f8bfed89e1c5af01. It amends section 7(4), inserts sections 7A and 7B, amends section 8 and makes no amendment to the Third Schedule. Read as at 22 September 2026. · Verified September 21, 2026